Peripheral Primitive Neuroectodermal Tumor
5 clinical trials · Condition
◉ Watch Peripheral Primitive Neuroectodermal Tumor
| Record | Firm | Date |
|---|---|---|
| Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD (NCT06068075) | Dana-Farber Cancer Institute | 2018-05-08 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma (NCT00516295) | National Cancer Institute (NCI) | 2008-02-01 |
| Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors (NCT00070109) | Children's Oncology Group | 2008-01-01 |
Track Peripheral Primitive Neuroectodermal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.